Showing results (841-850 of 895) with videos related to
Sort By:
Pageof 90
Drugs in R&D|May 29, 2023
A Randomized, Double-Blind, Parallel-Controlled Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of SCT510 to Bevacizumab (Avastin®) in Healthy Chinese MalesJing Wu, Guolan Wu, Liangzhi Xie, et al.Drugs in R&D|May 24, 2026
A Combination of the Tryptophan Hydroxylase Inhibitor Telotristat with the mTOR Inhibitor Everolimus as an Effective Strategy Against Neuroendocrine TumorsJavier Molina-Cerrillo, Arantzazu Sierra-Ramirez, José L López-Aceituno, et al.Drugs in R&D|March 12, 2026
Development and Evaluation of Multiple-Unit Tablets for the Controlled Release of LornoxicamYang Liu, Qiong-Zhi Shi, Yanchen Wang, et al.Drugs in R&D|June 21, 2006
Effect of D-004, a lipid extract from the Cuban royal palm fruit, on atypical prostate hyperplasia induced by phenylephrine in ratsM L Arruzazabala, R Más, V Molina, et al.Drugs in R&D|November 1, 2016
Distinct Glucose-Lowering Mechanisms of Ipragliflozin Depending on Body Weight ChangesEiji Kutoh, Teruma Murayama, Asuka Wada, et al.Drugs in R&D|November 14, 2016
Efficacy of Immunobiologic and Small Molecule Inhibitor Drugs for Psoriasis: A Systematic Review and Meta-Analysis of Randomized Clinical TrialsAndré Vicente Esteves de Carvalho, Rodrigo Pereira Duquia, Bernardo Lessa Horta, et al.Drugs in R&D|January 8, 2017
Identification of a Syndrome Class of Neuropsychiatric Adverse Reactions to Mefloquine from Latent Class Modeling of FDA Adverse Event Reporting System DataRemington L Nevin, Jeannie-Marie LeoutsakosDrugs in R&D|January 8, 2017
Vorapaxar: The Current Role and Future Directions of a Novel Protease-Activated Receptor Antagonist for Risk Reduction in Atherosclerotic DiseaseRebecca J Gryka, Leo F Buckley, Sarah M AndersonDrugs in R&D|December 23, 2016
Population Pharmacokinetics and Pharmacodynamics Modelling of Dilmapimod in Severe Trauma Subjects at Risk for Acute Respiratory Distress SyndromeShuying Yang, Teodora Pene DumitrescuDrugs in R&D|March 19, 2014
Managing the child with severe primary insulin-like growth factor-1 deficiency (IGFD): IGFD diagnosis and managementJay Cohen, Sandra Blethen, Joyce Kuntze, et al.Pageof 90